Quick Heal Technologies Limited (QUICKHEAL)
Updates
Q1FY27 results (unaudited):
Standalone:
Revenue 4.5bn -21.4% y-y (5.7bn)
EBITDA (1.8bn) -80.6% y-y ((0.97)bn)
EBITDA margin -39.1% (-17.0%) -2221 bps y-y
PAT (0.53bn) +4.2% y-y ((0.55)bn)
Consolidated:
Revenue 4.5bn -21.4% y-y (5.7bn)
EBITDA (1.8bn) -80.6% y-y ((0.97)bn)
EBITDA margin -39.1% (-17.0%) -2221 bps y-y
PAT (0.53bn) -3.6% y-y ((0.55)bn)
FY26 results (audited):
Standalone:
Revenue 26.1bn - y-y (prior year not stated)
EBITDA margin and EBITDA not derivable with confidence
PAT (1.0bn) - y-y (prior year not stated)
Consolidated:
Revenue 26.1bn - y-y (prior year not stated)
EBITDA margin and EBITDA not derivable with confidence
PAT (1.1bn) - y-y (prior year not stated)
Dividend: Not stated
Commentary: CEO emphasized focus on AI-driven cybersecurity growth agenda and operational excellence; CFO highlighted disciplined growth balancing investments with cash flow focus amid market headwinds.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 QUICKHEAL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add QUICKHEAL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Quick Heal Technologies Limited
Important.
The summary above is generated automatically from Quick Heal Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.